China Metachromatic Leukodystrophy (MLD) Treatment Market Research Report 2018

China Metachromatic Leukodystrophy (MLD) Treatment Market Research Report 2017

1 Metachromatic Leukodystrophy (MLD) Treatment Overview

1.1 Product Overview and Scope of Metachromatic Leukodystrophy (MLD) Treatment

1.2 Classification of Metachromatic Leukodystrophy (MLD) Treatment by Product Category

1.2.1 China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Comparison by Type (2012-2022)

1.2.2 China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Market Share by Type in 2016

1.2.3 AGT-183

1.2.4 DUOC-01

1.2.5 GSK-2696274

1.2.6 Others

1.3 China Metachromatic Leukodystrophy (MLD) Treatment Market by Application/End Users

1.3.1 China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 China Metachromatic Leukodystrophy (MLD) Treatment Market by Region

1.4.1 China Metachromatic Leukodystrophy (MLD) Treatment Market Size (Million USD) Comparison by Region (2012-2022)

1.4.2 South China Metachromatic Leukodystrophy (MLD) Treatment Status and Prospect (2012-2022)

1.4.3 East China Metachromatic Leukodystrophy (MLD) Treatment Status and Prospect (2012-2022)

1.4.4 Southwest China Metachromatic Leukodystrophy (MLD) Treatment Status and Prospect (2012-2022)

1.4.5 Northeast China Metachromatic Leukodystrophy (MLD) Treatment Status and Prospect (2012-2022)

1.4.6 North China Metachromatic Leukodystrophy (MLD) Treatment Status and Prospect (2012-2022)

1.4.7 Central China Metachromatic Leukodystrophy (MLD) Treatment Status and Prospect (2012-2022)

1.5 China Market Size (Sales and Revenue) of Metachromatic Leukodystrophy (MLD) Treatment (2012-2022)

1.5.1 China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (%)(2012-2022)

1.5.2 China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Metachromatic Leukodystrophy (MLD) Treatment Market Competition by Players/Manufacturers

2.1 China Metachromatic Leukodystrophy (MLD) Treatment Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.2 China Metachromatic Leukodystrophy (MLD) Treatment Revenue and Share by Players/Manufacturers (2012-2017)

2.3 China Metachromatic Leukodystrophy (MLD) Treatment Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)

2.4 China Metachromatic Leukodystrophy (MLD) Treatment Market Competitive Situation and Trends

2.4.1 China Metachromatic Leukodystrophy (MLD) Treatment Market Concentration Rate

2.4.2 China Metachromatic Leukodystrophy (MLD) Treatment Market Share of Top 3 and Top 5 Players/Manufacturers

2.4.3 Mergers & Acquisitions, Expansion in China Market

2.5 China Players/Manufacturers Metachromatic Leukodystrophy (MLD) Treatment Manufacturing Base Distribution, Sales Area, Product Types

3 China Metachromatic Leukodystrophy (MLD) Treatment Sales and Revenue by Region (2012-2017)

3.1 China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Market Share by Region (2012-2017)

3.2 China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Market Share by Region (2012-2017)

3.3 China Metachromatic Leukodystrophy (MLD) Treatment Price (USD/Pcs) by Regions (2012-2017)

4 China Metachromatic Leukodystrophy (MLD) Treatment Sales and Revenue by Type/ Product Category (2012-2017)

4.1 China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)

4.2 China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Market Share by Type (2012-2017)

4.3 China Metachromatic Leukodystrophy (MLD) Treatment Price (USD/Pcs) by Type (2012-2017)

4.4 China Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (%) by Type (2012-2017)

5 China Metachromatic Leukodystrophy (MLD) Treatment Sales by Application (2012-2017)

5.1 China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Market Share by Application (2012-2017)

5.2 China Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (%) by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 China Metachromatic Leukodystrophy (MLD) Treatment Players/Suppliers Profiles and Sales Data

6.1 ArmaGen Inc

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Metachromatic Leukodystrophy (MLD) Treatment Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.1.4 Main Business/Business Overview

6.2 GlaxoSmithKline Plc

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Metachromatic Leukodystrophy (MLD) Treatment Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.2.4 Main Business/Business Overview

6.3 Recursion Pharmaceuticals Inc

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Metachromatic Leukodystrophy (MLD) Treatment Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.3.4 Main Business/Business Overview

6.4 RegenxBio Inc

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Metachromatic Leukodystrophy (MLD) Treatment Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.4.4 Main Business/Business Overview

6.5 Shire Plc

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Metachromatic Leukodystrophy (MLD) Treatment Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.5.4 Main Business/Business Overview

...

7 Metachromatic Leukodystrophy (MLD) Treatment Manufacturing Cost Analysis

7.1 Metachromatic Leukodystrophy (MLD) Treatment Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Metachromatic Leukodystrophy (MLD) Treatment

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Metachromatic Leukodystrophy (MLD) Treatment Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Metachromatic Leukodystrophy (MLD) Treatment Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 China Metachromatic Leukodystrophy (MLD) Treatment Market Size (Sales and Revenue) Forecast (2017-2022)

11.1 China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)

11.2 China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Forecast by Type (2017-2022)

11.3 China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Forecast by Application (2017-2022)

11.4 China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

Figure Global and China Market Size (Million USD) Comparison (2012-2022)

Table Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type

Table Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Application (2016-2022)

Figure Product Picture of Metachromatic Leukodystrophy (MLD) Treatment

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Volume Market Share by Types in 2016

Figure AGT-183 Product Picture

Figure DUOC-01 Product Picture

Figure GSK-2696274 Product Picture

Figure Others Product Picture

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Comparison by Application (2012-2022)

Figure China Sales Market Share (%) of Metachromatic Leukodystrophy (MLD) Treatment by Application in 2016

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Others Examples

Table Key Downstream Customer in Others

Figure South China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure East China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure Northeast China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure North China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure Central China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (%)(2012-2022)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate (%)(2012-2022)

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales of Key Players/Manufacturers (2012-2017)

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Metachromatic Leukodystrophy (MLD) Treatment Sales Share (%) by Players/Manufacturers

Figure 2017 China Metachromatic Leukodystrophy (MLD) Treatment Sales Share (%) by Players/Manufacturers

Table China Metachromatic Leukodystrophy (MLD) Treatment Revenue by Players/Manufacturers (2012-2017)

Table China Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share (%) by Players/Manufacturers

Figure 2017 China Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share (%) by Players/Manufacturers

Table China Market Metachromatic Leukodystrophy (MLD) Treatment Average Price of Key Players/Manufacturers (2012-2017)

Figure China Market Metachromatic Leukodystrophy (MLD) Treatment Average Price of Key Players/Manufacturers in 2016

Figure China Metachromatic Leukodystrophy (MLD) Treatment Market Share of Top 3 Players/Manufacturers

Figure China Metachromatic Leukodystrophy (MLD) Treatment Market Share of Top 5 Players/Manufacturers

Table China Players/Manufacturers Metachromatic Leukodystrophy (MLD) Treatment Manufacturing Base Distribution and Sales Area

Table China Players/Manufacturers Metachromatic Leukodystrophy (MLD) Treatment Product Category

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Regions (2012-2017)

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales Share (%) by Regions (2012-2017)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Share (%) by Regions (2012-2017)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share (%) by Regions in 2016

Table China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Market Share by Regions (2012-2017)

Table China Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share (%) by Regions (2012-2017)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share (%) by Regions (2012-2017)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share (%) by Regions in 2016

Table China Metachromatic Leukodystrophy (MLD) Treatment Price (USD/Pcs) by Regions (2012-2017)

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Type (2012-2017)

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales Share (%) by Type (2012-2017)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Share (%) by Type (2012-2017)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share (%) by Type in 2016

Table China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Market Share by Type (2012-2017)

Table China Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share (%) by Type (2012-2017)

Figure Revenue Market Share of Metachromatic Leukodystrophy (MLD) Treatment by Type (2012-2017)

Figure Revenue Market Share of Metachromatic Leukodystrophy (MLD) Treatment by Type in 2016

Table China Metachromatic Leukodystrophy (MLD) Treatment Price (USD/Pcs) by Types (2012-2017)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (%) by Type (2012-2017)

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) by Applications (2012-2017)

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share (%) by Applications (2012-2017)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share (%) by Application (2012-2017)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share (%) by Application in 2016

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (%) by Application (2012-2017)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate (%) by Application (2012-2017)

Table ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Basic Information List

Table ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share (%) in China (2012-2017)

Figure ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share (%) in China (2012-2017)

Table GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Basic Information List

Table GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share (%) in China (2012-2017)

Figure GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share (%) in China (2012-2017)

Table Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Basic Information List

Table Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share (%) in China (2012-2017)

Figure Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share (%) in China (2012-2017)

Table RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Basic Information List

Table RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share (%) in China (2012-2017)

Figure RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share (%) in China (2012-2017)

Table Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Basic Information List

Table Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share (%) in China (2012-2017)

Figure Shire Plc Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share (%) in China (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Metachromatic Leukodystrophy (MLD) Treatment

Figure Manufacturing Process Analysis of Metachromatic Leukodystrophy (MLD) Treatment

Figure Metachromatic Leukodystrophy (MLD) Treatment Industrial Chain Analysis

Table Raw Materials Sources of Metachromatic Leukodystrophy (MLD) Treatment Major Players/Manufacturers in 2016

Table Major Buyers of Metachromatic Leukodystrophy (MLD) Treatment

Table Distributors/Traders List

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Price (USD/Pcs) Trend Forecast (2017-2022)

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Forecast by Type (2017-2022)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Forecast by Type (2017-2022)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Volume Market Share Forecast by Type in 2022

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Forecast by Application (2017-2022)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Volume Market Share Forecast by Application (2017-2022)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Volume Market Share Forecast by Application in 2022

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs) Forecast by Regions (2017-2022)

Table China Metachromatic Leukodystrophy (MLD) Treatment Sales Volume Share Forecast by Regions (2017-2022)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Volume Share Forecast by Regions (2017-2022)

Figure China Metachromatic Leukodystrophy (MLD) Treatment Sales Volume Share Forecast by Regions in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources